Skip to main content
TipRanks
Go Ultimate75% OFF

verbio Vereinigte BioEnergie (VBK) Q1 2027 Earnings Report

56 Followers

DE:VBK Q1 2027 EPS Results

Actual EPS
EUR 0.56
Consensus EPS
EUR 0.50
Beat/Miss
Beat by +EUR 0.06
One Year Ago EPS
-EUR 0.06

DE:VBK Q1 2027 Revenue Results

Actual Revenue
EUR 533.62M
Expected Revenue
EUR 534.80M
Beat/Miss
Missed by -EUR 1.18M
YoY Revenue Growth
+21.77%

Earnings Announcement Details

Quarter
Q1 2027
Date
11/12/2026
Time
Before Open
Conference Call
Thursday, November 12, 2026
DE:VBK Upcoming Earnings

verbio Vereinigte BioEnergie's next earnings date is estimated for February 11, 2027, based on past reporting schedules.

Q1 2027 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q1 2027 Earnings Slide Deck

No slide deck is available for this earnings event.

Q1 2027 Earnings Call Summary

Q1 2027
Earnings Call Date:Nov 12, 2026|% Change Since:-9.61%|
Earnings Call Sentiment|Positive

The call was clearly positive overall. Management reported a substantial year-on-year improvement in EBITDA, a swing to positive operating and free cash flow, lower net debt, stronger biodiesel markets, and increased confidence in achieving the upper end of the EUR 210 million to EUR 250 million EBITDA guidance range. Regulatory developments in Germany and Europe, Canadian production prospects, India expansion, and potential U.S. 45Z tax credits were additional positives. Offsetting issues included lower bioethanol production, weaker European bioethanol margins, temporary North American production problems, pressure and uncertainty in greenhouse gas quota pricing, below-full utilization at some U.S. plants, and the long commissioning timeline for Bitterfeld. The highlights significantly outweighed the lowlights.

Company Guidance

Management now expects group EBITDA for 2026, 2027 to come in at the upper end of its guidance range of EUR 210 million to EUR 250 million, with the first quarter performance not indicative for the full year run rate, a meaningful contribution from the greenhouse gas quota business, strong cash generation and a further significant reduction in net debt; it expects 2027 quota prices to be surely between EUR 400 and EUR 500, with the obligation growing by 5.5%, from EUR 12 million to EUR 17.5 million, while final 45Z guidance is expected in December and is not yet included. Management expects margins to stay on that level, with upside potential, expects to ramp both North American plants to full capacity, plans around about $30 million of investment in South Bend in 2027, expects first saleable Bitterfeld ethenolysis products at the end of November, December, and is planning to build up to 2 new plants in India.

  • Strong Start and Higher EBITDA GuidanceManagement described the first quarter as a strong start, with significantly improved underlying profitability and positive cash flow. Following the better-than-expected quarter and continued strong biodiesel spreads in Europe and North America, the company expects full-year 2026/27 EBITDA at the upper end of its EUR 210 million to EUR 250 million guidance range.
  • EBITDA Increased Significantly Year on YearGroup EBITDA increased to EUR 76.1 million in Q1 from EUR 15.4 million in Q1 of the prior year. The improvement was mainly driven by better margins in European biodiesel and bioethanol, strong Canadian biodiesel performance, and a higher contribution from the greenhouse gas quota business.
  • Positive Cash Flow and Lower Net DebtOperating cash flow improved from negative EUR 17.3 million in the prior-year quarter to positive EUR 34.1 million. Free cash flow was positive at EUR 13.5 million versus negative EUR 37.8 million a year earlier, helping reduce net debt from EUR 91.5 million at the end of June to EUR 83.1 million at the end of September. The equity ratio remained solid at 60%.
  • Biodiesel Production and Segment EBITDA GrowthBiodiesel production increased to 179,000 tonnes in Q1, with higher production in Europe and an even stronger increase in Canada. Biodiesel EBITDA rose from EUR 32 million in Q4 2025/26 to EUR 51 million in Q1, supported by a strong margin environment, higher biodiesel prices, feedstock purchases below market prices, and positive Canadian performance.
  • Biodiesel Sales Increased on Higher PricesBiodiesel sales increased to EUR 306 million from EUR 280 million in Q4, mainly reflecting higher biodiesel prices. Higher biodiesel prices more than compensated for higher feedstock costs, and the company's sourcing enabled realized margins above market spreads.
  • Improved Biodiesel Market EnvironmentEuropean biodiesel spreads recovered strongly during the quarter after very weak levels at the end of the prior financial year's Q4. Demand for rapeseed methyl ester was supported by the upcoming winter season, while low water levels on the Rhine and constrained rapeseed supply from Ukraine limited feedstock availability and supported biodiesel prices.
  • Biomethane Production Growth and Transport DemandBiomethane production increased to 359 gigawatt hours in Q1. Management also reported that registrations for CNG and LNG trucks have recently picked up, which it described as a positive sign for biomethane demand in heavy-duty transport. The company expects more trucks to improve utilization of its filling stations.
  • Greenhouse Gas Quota Market Remained StrongGreenhouse gas quota prices remained around EUR 500 to EUR 510 per tonne of CO2 equivalent during the quarter. The market benefited from a tighter supply-and-demand balance following RED III, the removal of double accounting, and difficult logistics caused by low water levels on the Rhine. The quota business made a higher year-on-year contribution.
  • Positive German Regulatory DevelopmentsGermany is taking tougher action against falsely declared biofuels. From January 2027, fuels with fraudulent sustainability documents can be excluded from the greenhouse gas quota system. Management said this strengthens compliant producers such as Verbio and that customers are increasingly seeking reliable partners with compliant supply chains.
  • European Policy Support for Renewable FuelsThe European Parliament's Environment Committee adopted a proposal recognizing vehicles running only on eligible renewable fuels as zero-emission vehicles, with a plenary vote expected in December. Management also cited growing support for E20 and B10, which would allow more renewable fuels to be used in the existing vehicle fleet.
  • Canadian Plant Production ExtendedStrong biodiesel margins allowed the company to change its plans for the Welland plant in Canada. Instead of the originally planned winter shutdown, production can continue through most of the winter. Management also said the proposed Canadian CFR multiplier for domestic production could provide additional upside for Welland.
  • North American Plant Issues Addressed and Utilization RampingManagement said production issues at the North American plants were fixed after work throughout the summer. Nevada utilization was approximately 60% to 70% and was being ramped toward full capacity, while South Bend utilization was approximately 70% after resolving dryer issues experienced in spring 2026.
  • South Bend Biogas Investment and 45Z OpportunityThe company has started building the biogas plant at South Bend, with six or eight digesters already built. It plans to invest around USD 30 million in South Bend in 2027 and use crude gas in its boiler to replace natural gas and generate U.S. 45Z tax credits.
  • India Biogas Market ExpansionManagement reported strong dynamics in India's biogas market, including a new program with CapEx subsidies and a 40% increase in the price for compressed biogas. State-owned companies are required to build up to 200 plants collectively. Verbio is continuing to establish its announced joint venture with GAIL and plans to build up to two new plants with the joint venture.
  • Bitterfeld Ethenolysis Project ProgressThe Bitterfeld ethenolysis plant remains in commissioning, with the first saleable products expected at the end of November or in December. Management said customers are waiting for the product and described the project as a long-term opportunity to convert rapeseed methyl ester into higher-margin chemical products, while noting that development will take years.
  • Stable Investment Level and Ongoing ProjectsInvestments remained broadly stable at around EUR 20 million in Q1, mainly related to the specialty chemicals project in Bitterfeld, biogas production in South Bend, and efficiency measures. Management said the company remains focused on increasing utilization of existing assets rather than building new plants.
  • Continued Confidence in U.S. Ethanol MarginsManagement said global ethanol demand is growing and that U.S. corn ethanol is the cheapest molecule. It expects global demand to continue growing in 2027 and said margins were already very good in 2026, with expectations that margins will at least stay at that level and could have upside potential.
  • Potential U.S. 45Z Tax Credit UpsideManagement expects there will be a 45Z tax credit contribution but is not including it in current guidance until final guidance is available in December. The potential impact also depends on the Climate-Smart Act and the carbon intensity associated with fertilizer use in corn production.

DE:VBK Earnings History

DE:VBK earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 11, 20272027 (Q2)―-0.05――
Nov 12, 20262027 (Q1)0.500.56-0.061033.33% (+0.62)
Sep 24, 20262026 (Q4)0.870.65-1.52142.62% (+2.17)
May 13, 20262026 (Q3)0.330.36-0.22263.64% (+0.58)
Feb 12, 20262026 (Q2)0.090.05-0.06190.91% (+0.10)
Nov 12, 20252026 (Q1)-0.03-0.06-0.3683.33% (+0.30)
Sep 25, 20252025 (Q4)-0.32-1.520.13-1273.08% (-1.66)
May 13, 20252025 (Q3)-0.10-0.22-0.18-22.22% (-0.04)
Feb 12, 20252025 (Q2)-0.17-0.060.01-650.00% (-0.07)
Nov 12, 20242025 (Q1)0.03-0.360.34-205.88% (-0.70)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed